Ensuring that individuals living with dementia have a voice and control in their healthcare decisions is a critical issue that often goes underappreciated. And here’s where it gets interesting: a new innovative resource is now empowering those affected by dementia to communicate more effectively with their medical team about their medications—boosting their confidence and participation in the decision-making process.
This initiative introduces a helpful tool and accompanying website, both developed collaboratively with input from consumers—people living with dementia—and their caregivers. These resources aim to enhance understanding of one’s health needs and facilitate clearer communication with healthcare providers. An added benefit is the potential reduction in the number of medications prescribed, especially those that might be unnecessary or harmful.
Dr. Nagham Ailabouni from The University of Queensland’s School of Pharmacy and Pharmaceutical Sciences explains that the PRIME tool—short for PReparing people living with dementia to Initiate conversations about their MEdicines—is crafted specifically for individuals experiencing memory issues, whether due to Alzheimer’s disease, general dementia, or mild cognitive impairment.
“Starting conversations with healthcare professionals can be intimidating for both people with dementia and their carers,” notes Dr. Ailabouni. “They have voiced a strong desire for a resource to help them navigate these often complex discussions.” She further explains that many users have reported that using the PRIME tool boosts their confidence, encouraging them to ask pertinent questions. This, in turn, can lead to more thorough medication reviews, potentially decreasing the number of medications that might be inappropriate or risky.
The ultimate goal is to make medication management easier for consumers, which can significantly boost their overall health and sense of wellbeing.
In addition to the printed tools, Dr. Ailabouni co-developed a website—kindmeds.org—that serves as a platform where users can download the PRIME resource. They can either print it out and fill it in at their own pace or complete it online ahead of medical visits. This flexible design ensures that consumers can prepare themselves thoroughly before discussing their medications with healthcare professionals.
What sets this project apart is its collaborative development process; both the tool and website were created with active input from individuals living with dementia and their carers. This approach ensures the resources are truly user-friendly, informative, and relevant to real needs.
Furthermore, the PRIME tool isn't limited to those with memory problems. It has been adapted for older adults who may not have cognitive impairments but still benefit from structured guidance during medical consultations. Currently, the tool is available in English and Chinese, with plans to introduce more languages soon.
This pioneering research, published in the Journal of Alzheimer’s Disease, reflects a significant step forward in empowering dementia patients and their families to participate actively in healthcare decisions.
Collaborative partners in this project include Monash University, The University of Sydney, University of Maryland Baltimore, University of Bern, University of South Australia, and Dementia Australia, highlighting a broad and multidisciplinary effort to improve patient-centered care.
